Sailaja Puttagunta

ITRM

CHIEF MEDICAL OFFICER · ITERUM THERAPEUTICS PLC · CIK 0001792314

FILING MIX · LIFETIME64%/36%

BUYS

SELLS

TOTAL VALUE

$10.7K

COMPANIES

ACTIVE SINCE

Mar 2020

HOLDINGS NOW

84,552

AVG SELL PX

$1.69

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

1 backtested trades · 8 horizons

Forward-return performance of every backtestable P/S trade by Sailaja Puttagunta, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	1	+100.00%	-14.75%	-3.35%	-11.40%	-11.40%	—
14d	1	+100.00%	-21.58%	-5.38%	-16.21%	-16.21%	—
30d	1	+100.00%	-39.57%	-5.58%	-33.98%	-33.98%	—
60d	1	+0.00%	+0.00%	+0.35%	-0.35%	-0.35%	—
90d	1	+100.00%	-17.27%	-1.79%	-15.48%	-15.48%	—
180d	1	+100.00%	-17.27%	+3.55%	-20.82%	-20.82%	—
1y	1	+0.00%	+52.52%	+14.60%	+37.92%	+37.92%	—
2y	1	+0.00%	+71.94%	+52.72%	+19.22%	+19.22%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

ITRM · 13,302 shares · as of Dec 1, 2023

Trading cadence · quarterly flow

BUY ● SELL ●

2020

2021

2022

2023

FLOW · 7 buys / 4 sellsCOVERAGE · 16 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
ITRM ITERUM THERAPEUTICS PLC	SALE Chief Medical Officer	8,333	—	—	16,666	Dec 1, 2023	Dec 4, 2023 ↗	View →
ITRM ITERUM THERAPEUTICS PLC	SALE Chief Medical Officer	2,933	$2.12	$6.2K	10,369	Dec 1, 2023	Dec 4, 2023 ↗	View →
ITRM ITERUM THERAPEUTICS PLC	PURCHASEGRANT Stock grant	8,333	—	—	13,302	Dec 1, 2023	Dec 4, 2023 ↗	View →
ITRM ITERUM THERAPEUTICS PLC	PURCHASEGRANT Stock grant	75,000	—	—	75,000	Mar 31, 2023	Apr 3, 2023 ↗	View →
ITRM ITERUM THERAPEUTICS PLC	SALE Chief Medical Officer	3,365	$1.32	$4.4K	4,969	Dec 2, 2022	Dec 5, 2022 ↗	View →
ITRM ITERUM THERAPEUTICS PLC	PURCHASEGRANT Stock grant	8,334	—	—	8,334	Dec 1, 2022	Dec 5, 2022 ↗	View →
ITRM ITERUM THERAPEUTICS PLC	SALE Chief Medical Officer	8,334	—	—	24,999	Dec 1, 2022	Dec 5, 2022 ↗	View →
ITRM ITERUM THERAPEUTICS PLC	PURCHASEGRANT Stock grant	1,800,000	—	—	1,800,000	Dec 10, 2021	Dec 14, 2021 ↗	View →
ITRM ITERUM THERAPEUTICS PLC	PURCHASEGRANT Stock grant	500,000	—	—	500,000	Dec 10, 2021	Dec 14, 2021 ↗	View →
PHGE BIOMX INC.	PURCHASEGRANT Stock grant	71,250	—	—	71,250	Mar 30, 2021	Apr 1, 2021 ↗	View →
PHGE BIOMX INC.	PURCHASEGRANT Stock grant	67,500	—	—	67,500	Mar 25, 2020	Mar 27, 2020 ↗	View →

Other insiders · ITRM

Loading peer insiders…

About this filer

CIK 0001792314

ROLE

Chief Medical Officer

PRIMARY

ITRM

COMPANIES

ACTIVE SINCE

Mar 2020

MARKETPEEL · /INSIDER/0001792314DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Sailaja Puttagunta

The morning brief, before the bell.